Back to Search Start Over

Novel methylenecyclopropyl-based acyl-CoA dehydrogenase inhibitor.

Authors :
Broadway NM
Engel PC
Source :
FEBS letters [FEBS Lett] 1998 Oct 16; Vol. 437 (1-2), pp. 122-6.
Publication Year :
1998

Abstract

A novel hexyl-substituted methylenecyclopropyl acetyl-CoA was tested as an enzyme-specific acyl-CoA dehydrogenase inhibitor. Its CoA ester generated in situ from the carboxylic acid and CoASH, displayed marked differences in inhibition specificity as compared to methylenecyclopropyl acetyl-CoA, consistent with the substrate specificities of the target enzymes. Thus methylenecyclopropyl acetyl-CoA inactivated short-chain-specific acyl-CoA dehydrogenase rapidly, medium-chain-specific acyl-CoA dehydrogenase much more slowly and had no effect on long-chain- or very long-chain-specific acyl-CoA dehydrogenases. The hexyl-substituent on the methylenecyclopropyl ring gave an inhibitor which rapidly inactivated MCAD and LCAD whilst VLCAD was inhibited more slowly and SCAD was essentially unaffected. In some cases (e.g. SCAD and MCPA-CoA) inhibition was accompanied by flavin bleaching. In other cases (e.g. LCAD and C6MCPA) less pronounced bleaching suggests a different chemistry of inhibition.

Details

Language :
English
ISSN :
0014-5793
Volume :
437
Issue :
1-2
Database :
MEDLINE
Journal :
FEBS letters
Publication Type :
Academic Journal
Accession number :
9804184
Full Text :
https://doi.org/10.1016/s0014-5793(98)01155-7